Haleon (HLNCF)
PNK: HLNCF
· Real-Time Price · USD
5.17
0.13 (2.48%)
At close: May 01, 2025, 2:11 PM
2.48% (1D)
| Bid | 4.95 |
| Market Cap | 46.64B |
| Revenue (ttm) | 11.23B |
| Net Income (ttm) | 1.44B |
| EPS (ttm) | 0.21 |
| PE Ratio (ttm) | 24.62 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 5.41 |
| Volume | 136 |
| Avg. Volume (20D) | 19,920 |
| Open | 5.17 |
| Previous Close | 5.04 |
| Day's Range | 5.17 - 5.17 |
| 52-Week Range | 3.93 - 5.47 |
| Beta | 0.23 |
About HLNCF
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensod...
Sector Healthcare
IPO Date Jul 28, 2022
Employees 24,561
Stock Exchange PNK
Ticker Symbol HLNCF
Website https://www.haleon.com